a b c
d e f
g h i
j k l
m n o
p q r s
t u v
w x y z
|
|
||
|
Product |
Code |
Section |
|
S-100 Protein |
NCL-S100 |
Neural Tissue and Tumour Markers |
|
S-100 Protein |
NCL-S100p |
Neural Tissue and Tumour Markers |
|
S-100 Protein (Liquid Primary Antibody) |
NCL-L-S100p |
Neural Tissue and Tumour Markers |
|
S-100 Protein (Ready to Use) |
RTU-S100p |
Neural Tissue and Tumour Markers |
|
Sarcoglycan, Alpha (Adhalin) |
NCL-a-SARC |
Muscle Disease |
|
Sarcoglycan, Alpha (Adhalin) (Liquid Primary Antibody) |
NCL-L-a-SARC |
Muscle Disease |
|
Sarcoglycan, Beta |
NCL-b-SARC |
Muscle Disease |
|
Sarcoglycan, Beta (Liquid Primary Antibody) |
NCL-L-b-SARC |
Muscle Disease |
|
Sarcoglycan, Delta |
NCL-d-SARC |
Muscle Disease |
|
Sarcoglycan, Gamma |
NCL-g-SARC |
Muscle Disease |
|
Sarcoplasmic or Endoplasmic Reticulum Ca2+ATPase 1 |
NCL-SERCA1 |
Special Interest |
|
Sarcoplasmic or Endoplasmic Reticulum Ca2+ATPase 2 |
NCL-SERCA2 |
Special Interest |
|
Secretory Component, Human |
NCL-SCO5 |
Special Interest |
|
Secretory Leukocyte Protease Inhibitor |
NCL-SLPI |
Lymphoid Markers |
|
Securin, Human |
NCL-SECURIN |
Cell Cycle Associated Markers |
|
Serotonin |
NCL-SEROTp |
Neural Tissue and Tumour Markers |
|
Serum, Normal Goat (Blocking Reagent) |
NCL-G-SERUM |
Secondary Detection Systems and Reagents |
|
Serum, Normal Horse (Blocking Reagent) |
NCL-H-SERUM |
Secondary Detection Systems and Reagents |
|
Serum, Normal Rabbit (Blocking Reagent) |
NCL-R-SERUM |
Secondary Detection Systems and Reagents |
|
Serum, Normal Swine (Blocking Reagent) |
NCL-S-SERUM |
Secondary Detection Systems and Reagents |
|
Sheep Anti-Mouse FITC-Conjugated Immunoglobulin |
NCL-SAM-FITC |
Flow Cytometry |
|
Sialyl Lewisa (CA19-9) |
NCL-CA19-9 |
Tumour Markers |
|
Sialyl Lewisa (CA19-9) (Liquid Primary Antibody) |
NCL-L-CA19-9 |
Tumour Markers |
|
SLAM (CDw150) New in 2002 |
NCL-SLAM |
Cellular Adhesion Molecules |
|
Small Intestinal Mucinous Antigen |
NCL-SIMA |
Tumour Markers |
|
Smooth Muscle Actin, Alpha |
NCL-SMA |
Small and Intermediate Filaments |
|
Smooth Muscle Actin, Alpha (Ready to Use) |
RTU-SMA |
Small and Intermediate Filaments |
|
SNAP-25 |
NCL-SNAP-25 |
Neural Tissue and Tumour Markers |
|
Somatostatin |
NCL-SOMATOp |
Hormones |
|
Spasmolytic Polypeptide, Human |
NCL-HSP |
Special Interest |
|
Spectrin (recommended for human use) |
NCL-SPEC1 |
Muscle Disease |
|
Spectrin (broad spectrum) |
NCL-SPEC2 |
Muscle Disease |
|
Staphylococcus aureus, Methicillin-Resistant (Primer Set) |
NCL-SA-PS |
Microbiology/Virology |
|
Stat 1 Alpha |
NCL-STAT1A |
Cell Cycle Associated Markers |
|
Streptococcus pneumoniae (Pneumolysin) |
NCL-SPNm |
Microbiology/Virology |
|
Streptococcus pneumoniae (Primer Set) |
NCL-SP-PS |
Microbiology/Virology |
|
Superoxide Dismutase (Cu/Zn) |
NCL-SOD1 |
Special Interest |
|
Surfactant Precursor Protein B |
NCL-SPPB |
Tumour Markers |
|
Swine, Normal Serum (Blocking Reagent) |
NCL-S-SERUM |
Secondary Detection Systems and Reagents |
|
Synapsin I |
NCL-SYNAPSIN I |
Neural Tissue and Tumour Markers |
|
Synaptophysin |
NCL-SYNAP-299 |
Neural Tissue and Tumour Markers |
|
Synaptophysin (Liquid Primary Antibody) |
NCL-L-SYNAP-299 |
Neural Tissue and Tumour Markers |
|
Synaptophysin (Ready to Use) |
RTU-SYNAP-299 |
Neural Tissue and Tumour Markers |
|
Synaptophysin |
NCL-SYNAPp |
Neural Tissue and Tumour Markers |
|
Synaptophysin |
NCL-SYNAPTOp |
Neural Tissue and Tumour Markers |
|
Syndecan-1 (CD138) |
NCL-CD138 |
Cluster Differentiation Markers |
|
Synuclein, Alpha |
NCL-ASYN |
Neural Tissue and Tumour Markers |
|
Synuclein, Alpha (Liquid Primary Antibody) |
NCL-L-ASYN |
Neural Tissue and Tumour Markers |